Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Roselle refers to the plant *Hibiscus sabdariffa*, which is widely utilized in traditional medicine and as a dietary supplement for its antioxidant and antihypertensive properties. In a specific clinical context, **NW Roselle** is a powdered medicinal product developed by Natural Wellness that combines extracts from *Hibiscus sabdariffa* flowers and *Olea europaea* (olive) leaves. This combination is primarily investigated for the treatment of Grade 1 essential hypertension, where it is thought to exert therapeutic effects through angiotensin-converting enzyme (ACE) inhibition, diuretic activity, and vasodilatory mechanisms. Beyond hypertension, roselle extracts have been studied for their potential to reduce insulin resistance in type 2 diabetes and for their in vitro cytotoxic effects against oral squamous cell carcinoma cells, likely mediated by high concentrations of anthocyanins, polyphenols, and flavonoids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on roselle.